| Name: | Imatinib pyridine N oxide Impurity |
| Catalogue No. | VL272010 |
| CAS No. | 571186-92-0 |
| Molecular Formula | C₂₉H₃₁N₇O₂ |
| Molecular Weight | 509.6 |
| Status | In-stock |
| IUPAC Name | N-[4-Methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide |
| Description | Imatinib pyridine N oxide Impurity (CAS No: 571186-92-0) Or N-[4-Methyl-3-[[4-(1-oxido-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide, is an impurity of imatinib, it is used in the treatment of chronic myeloid leukaemia. |
| References | Sci-Hub | Association of the Trough, Peak/Trough Ratio of Imatinib, PyridineâN-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients | 10.3389/fonc.2020.01348. (2020). Retrieved December 9, 2021, from Hkvisa.net website: https://sci-hub.hkvisa.net/10.3389/fonc.2020.01348 |
